Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of H9N2 Influenza Vaccine in Healthy Adults
NCT01320696Phase 2Completed
- Sponsor
- Resilience Government Services
- Start
- Mar 2011
- Primary completion
- Jun 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of A/H9N2 influenza vaccine in H9N2 avian influenza (H9N2), sponsored by Resilience Government Services. Started Mar 2011; status: completed.
02
Drugs
A/H9N2 influenza vaccine
03
Conditions
H9N2 avian influenza (H9N2)
Beyond the preview
Go deeper on NCT01320696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01320696.